HUTCHMED (China) Limited (HKG:0013)
23.76
-0.70 (-2.86%)
Oct 17, 2025, 4:08 PM HKT
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of 19.67 billion as of October 17, 2025. Its market cap has decreased by -27.40% in one year.
Market Cap
19.67B
Enterprise Value
10.16B
Revenue
4.73B
Ranking
n/a
PE Ratio
5.37
Stock Price
23.76
Market Cap Chart
Since May 19, 2006, HUTCHMED (China)'s market cap has increased from 1.87B to 19.67B, an increase of 954.13%. That is a compound annual growth rate of 12.89%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 17, 2025 | 19.67B | 0.71% |
Dec 31, 2024 | 19.53B | -18.73% |
Dec 29, 2023 | 24.03B | 14.66% |
Dec 30, 2022 | 20.96B | -56.27% |
Dec 31, 2021 | 47.93B | 35.91% |
Dec 31, 2020 | 35.26B | 35.08% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeOne Medicines AG | 272.08B |
Hansoh Pharmaceutical Group Company | 216.37B |
JD Health International | 205.69B |
WuXi Biologics | 148.98B |
Innovent Biologics | 148.75B |
Sino Biopharmaceutical | 136.94B |
Akeso | 117.72B |
Sichuan Kelun-Biotech Biopharmaceutical | 106.89B |